A mathematical model of hiPSC cardiomyocytes electromechanics

© 2021 The Authors. Physiological Reports published by Wiley Periodicals LLC on behalf of The Physiological Society and the American Physiological Society..

Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) are becoming instrumental in cardiac research, human-based cell level cardiotoxicity tests, and developing patient-specific care. As one of the principal functional readouts is contractility, we propose a novel electromechanical hiPSC-CM computational model named the hiPSC-CM-CE. This model comprises a reparametrized version of contractile element (CE) by Rice et al., 2008, with a new passive force formulation, integrated into a hiPSC-CM electrophysiology formalism by Paci et al. in 2020. Our simulated results were validated against in vitro data reported for hiPSC-CMs at matching conditions from different labs. Specifically, key action potential (AP) and calcium transient (CaT) biomarkers simulated by the hiPSC-CM-CE model were within the experimental ranges. On the mechanical side, simulated cell shortening, contraction-relaxation kinetic indices (RT50 and RT25 ), and the amplitude of tension fell within the experimental intervals. Markedly, as an inter-scale analysis, correct classification of the inotropic effects due to non-cardiomyocytes in hiPSC-CM tissues was predicted on account of the passive force expression introduced to the CE. Finally, the physiological inotropic effects caused by Verapamil and Bay-K 8644 and the aftercontractions due to the early afterdepolarizations (EADs) were simulated and validated against experimental data. In the future, the presented model can be readily expanded to take in pharmacological trials and genetic mutations, such as those involved in hypertrophic cardiomyopathy, and study arrhythmia trigger mechanisms.

Medienart:

E-Artikel

Erscheinungsjahr:

2021

Erschienen:

2021

Enthalten in:

Zur Gesamtaufnahme - volume:9

Enthalten in:

Physiological reports - 9(2021), 22 vom: 17. Nov., Seite e15124

Sprache:

Englisch

Beteiligte Personen:

Forouzandehmehr, Mohamadamin [VerfasserIn]
Koivumäki, Jussi T [VerfasserIn]
Hyttinen, Jari [VerfasserIn]
Paci, Michelangelo [VerfasserIn]

Links:

Volltext

Themen:

3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester
71145-03-4
Action potential
CJ0O37KU29
Calcium Channel Agonists
Calcium Channel Blockers
Contractility
Drug test
Human stem cell-derived cardiomyocyte
Immature cardiomyocytes
In silico modeling
Journal Article
Research Support, Non-U.S. Gov't
Verapamil

Anmerkungen:

Date Completed 16.03.2022

Date Revised 04.04.2024

published: Print

Citation Status MEDLINE

doi:

10.14814/phy2.15124

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM333626435